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Objective: We tested the effects of structured health care for the diabetic foot in one region in Germany aiming to
reduce the number of major amputations.
Research design and methods: In a prospective study we investigated patients with diabetic foot in a structured
system of outpatient, in-patient and rehabilitative treatment. Subjects were recruited between January 1st, 2000 and
December 31, 2007. All participants underwent a two-year follow-up. The modified University of Texas Wound
Classification System (UT) was the basis for documentation and data analysis. We evaluated numbers of major
amputations, rates of ulcer healing and mortality. In order to compare the effect of the structured health care
program with usual care in patients with diabetic foot we evaluated the same parameters at another regional
hospital without interdisciplinary care of diabetic foot (controls).
Results: 684 patients with diabetic foot and 508 controls were investigated. At discharge from hospital 28.3%
(structured health care program, SHC) vs. 23.0% (controls) of all ulcers had healed completely. 51.5% (SHC) vs. 49.8%
(controls) were in UT grade 1.
Major amputations were performed in 32 subjects of the structured health care program group (4.7%) vs. 110
(21.7%) in controls (p<0.0001). Mortality during hospitalization was 2.5% (SHC) vs. 9.4% in controls (p<0.001).
Conclusions: With the structured health care program we achieved a significant reduction of major amputation
rates by more than 75% as compared to standard care.Background
Foot ulcers are a major complication in patients with
diabetes and remain one of the most common causes for
hospitalization and the high costs associated with this
disease. Unfortunately, lower extremity amputation
(LEA) is a frequent and disabling consequence of diabetes.
Major determinants in the pathway to limb loss are
peripheral sensomotoric neuropathy, ulceration, infection,
and peripheral vascular disease [1-4]. The classification of
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reproduction in any medium, provided the orstaging the diabetic foot wound situation according to the
modified University of Texas Wound Classification
System (modified UT). The extent of the foot wound is
graded by Wagner [5] and the staging of the wound
situation is described according to Armstrong et al. [1].
The outcome, especially with respect to LEA, appears to
deteriorate with increasing grade and stage of the foot
wounds.
It is generally accepted that LEA may potentially be
avoided in many patients if a more consequent and
aggressive therapeutic regimen would be applied. For
example, it has been stated that the deficits in the health
care structures related to the treatment of diabetes in
Germany and western Europe are especially obvious in
patients suffering from diabetic foot. Patients withtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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than people without the disease. Recently the numbers
of LEA in Germany were calculated based on current
health insurance data. Based on these data, about 20,000
major amputations in subjects with diabetes have been
carried out in the year 2003 alone and over the past ten
years, the number of amputations per year have not
declined in Germany [6]. All this reflects the urgent need
to improve the organization of our existing health
care structures and there is general consent that the
introduction of specific disease management or structured
health care programs for diabetic foot may be of great
benefit.
The purpose of this study was to establish and validate
a structured health care program (SHC) for the diabetic
foot introduced in the Southeast of Germany near
Dresden compared to standard care of diabetic foot. The
primary objective of this structured health care program
was to reduce the number of LEA. The modified UT-
system served as basis for documentation and data ana-
lysis of the diabetic foot SHC program.Research design and methods
Design
First, a contract regulating the organization of a SHC
based on integrated outpatient treatment, acute in-patient
care and rehabilitative treatment was set up and signed by
three large and established institutions responsible for the
treatment of diabetic foot in the Dresden region (local
branch of Germany’s largest Health Insurance Company
(AOK), a hospital specialized in acute treatment of
diabetic foot (Weißeritztal-Kliniken Freital-Dippoldiswalde),
and a specialized rehabilitation clinic, (Clinic BAVARIA
Kreischa).
The inclusion of subjects with diabetes with new foot
ulcers was scheduled over a time frame of 8 years with a
follow-up investigation period for each individual patient
over 2 years.
Patients with diabetic foot were referred to the inter-
disciplinary diabetic foot ward of the hospital, by general
practitioners, specialized diabetes outpatient depart-
ments, or other specialists. At the interdisciplinary dia-
betic foot ward, initial diagnostic procedures were
carried out and treatment started. Thereafter, the pa-
tients were transferred to the rehabilitation clinic. After
discharge of the patients from rehabilitation clinic, a
diabetic foot outpatient department carried out semi-
annual check-up’s including all necessary further individ-
ual interventions over a time frame of two years.
In order to accomplish a standardized clinical proced-
ure, all participating medical institutions shared a
common set of diagnostic and therapeutic algorithms
(Figure 1). A handbook explaining the standards wasavailable for all professionals involved [7]. All instances
were subject to supervision by senior specialists in
diabetes (MW, TS, UD).
In Germany there is no central amputation registry or
specific data available from Health Insurance Companies.
In order to compare the results of the SHC with the usual
care of subjects with diabetic foot we recruited a control
group at another regional hospital without interdisciplin-
ary care of diabetic foot.Study population and procedure
1475 subjects were hospitalized because of diabetic foot
ulceration between January 1st 2000 and December 31st
2007. 742 patients out of this group, covered by AOK
insurance and presenting with a recently manifested
foot ulcer were enrolled consecutively into this obser-
vational and prospective study. Exclusion criteria were
acute myocardial infarction or stroke within the last 6
months, terminal renal failure or any kind of cancer.
Based on these criteria 58 subjects were excluded
from the study. All other patients were covered by
other Health Insurance Companies. Therefore, 684
subjects with diabetic foot ulceration were suitable for
data analysis.
In the control hospital, 560 patients admitted because
of diabetic foot were recruited between January 1st 2005
and December 31th 2007. Because of the mentioned
criteria 52 subjects were excluded and 508 patients were
suitable for data analysis. Health insurance of these
subjects was covered by several insurance companies
including AOK.
In addition to foot inspection, the physical examin-
ation of the patients included the palpation of periph-
eral pulses and the evaluation of vibration perception
threshold with the calibrated Rydell-Seiffer tuning fork
at the ankle. Each ulcer was graded and staged using
modified UT system.
All patients received identical standard ulcer wound
care including use of proper footwear, non-weight bearing
limb support, daily wound debridement and careful
clinical monitoring. In the case of clinical signs of soft tis-
sue infection or a corresponding antibiogram, antibiotics
were prescribed.
The assessment of perfusion included as first line
evaluation the palpation of pedal pulses and the
measurement of the ankle-brachial index (ABI) using a
handheld Doppler device. With this procedure we classi-
fied PAD as follows:
Because of false high ABI in subjects with MAC we
used continuous wave (cw) Doppler sonography for
more detailed analysis of perfusion. We considered
compensated perfusion if the increasing wing of the
Doppler curve was more steep as the decreasing
Figure 1 Clinical pathway of diagnosis and treatment of diabetic foot in the structured health care group.
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sidered as decompensated perfusion or critical limb
ischemia.
With these measures we subdivided the patients with
diabetic foot into 4 categories:
1. undisturbed perfusion (0.9 < ABI < 1.3)
2. disturbed but compensated perfusion
(0.5 < ABI < 0.9)
3. decompensated perfusion and critical limb ischemia
(ABI < 0.5)
4. medial arterial calcification (MAC) (ABI > 1.3)
Patients with signs of ischemia (decompensated ische-
mia) were seen by the interventional angiologist and the
vascular surgeon. If vascular reconstruction or inter-
ventional radiologic procedures were not possible,
prostaglandins, low-dose urokinase or autologous bone
marrow derived mononuclear cells (“stem cells”, intra-
muscular application) were applied in order to improve
perfusion [8].Patients were transferred to the rehabilitation center
if acute treatment of the diabetic foot was completed.
At the rehabilitation center the treatment procedures
of the foot ulcer were continued and combined with
an intensified diabetes education program.
The patients were discharged if the diabetic foot wound
was healed completely or an outpatient treatment was
possible. Before discharge the subjects received definitive
individual therapeutic footwear according to the proposals
of the German Diabetes Association [9] and the recom-
mendations by Dahmen et al. [10]. The orthopaedic
shoes were designed based on measurements of the
plantar pressure using the Fastscan in shoe pressure
analysis system.
All subjects gave their written informed consent before
participating in this study. The study was approved by
the local ethics committee.
Statistical analysis
Data analysis was performed using the IBM SPSS
Statistics 19.0 software (SPSS Inc. IBM Company
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in order to assess normal distribution of each quanti-
tative parameter. Data are expressed as mean ±
standard deviation (SD) or as median. Statistical sig-
nificance was defined as a two-tailed p value of less
than 0.05. Differences in means between the groups
were tested with the t-test for independent samples
(normal distribution), Mann–Whitney-U- Test (not
normal distribution) or Chi-square-test in categorical
variables.
To test the difference of grade and stage of diabetic foot
ulcer between the treatment groups at entry into the study
we used the t-test for independent samples with adjust-
ment of age and PAD. To test the differences of clinical
and patient relevant endpoints (mortality, grade and stage
of the foot ulcers between both groups at the end of hos-
pital treatment, amputations) we used ANCOVA with ad-
justment of age, adjustment of grade and stage of the
diabetic foot at baseline PAD, history of CHD, hyperten-
sion, smoking and MA. For a better quantification of the
different grades and stages of diabetic foot in the modified
UT classification we implemented a digitalization as fol-
lows (Table 1).
This means that depending on the extent of grade and
stage of diabetic foot disease defined by the modified UT
system the numerical value of the codes is increased. Thus,
based on this method it is possible to calculate and com-
pare median values for the grade and stage of diabetic foot.Table 1 Digitalization of the different grades and stages
of diabetic foot ulcers according to the modified UT
classification
Grade and stage of diabetic foot according to


















684 subjects with newly detected diabetic foot ulcer were
consecutively included into the structured health care pro-
gram and 508 controls were consecutively enrolled into
the study. The mean age of the population of the struc-
tured health care program was 66.9 ± 10.5 years. Controls
were significantly older (71.4 ± 10.8 years; p<0,001).
Diabetes duration (16.1 ± 10.2 vs. 15.8 ± 9.5 years),
HbA1C (61.8 ± 14.2 vs. 61.8 ± 14.2 mmol/mol and 7.8 ±
1.8 vs. 7.8 ± 1.8%), BMI (29.7 ± 5.8 vs 29.2 ± 5.7 kg/m2)
and blood pressure (139 ± 21/76 ±11 vs. 140 ± 25/76 ±
13 mmHg) were comparable between the structured
health care program and controls.
With respect to the classification of ulcers (neuro-
ischemic, neuropathic, ischemic), the rate of infection
and diabetic complications both groups were comparable.
The severity of foot ulcers according to the modified
UT system was not significantly different between both
groups (Figure 2).
The results of the angiological examinations showed
that only 7% of the patients of the structured health careFigure 2 Comparison of ulcer healing rates according to the
modified University of Texas wound classification system
between subjects with diabetic foot treated by the structured
health care program or standard care (controls) test of the
structured health care program vs. controls at baseline: t-test
with adjustment of age; test of change between admission and
discharge: ANCOVA with adjustment of age, adjustment of
grade and stage of the diabetic foot at baseline, PAD, history
of CHD, hypertension, smoking and MA.* The severity of the
diabetic foot was calculated according to a coding system described
in the text. SHC structured health care program.
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controls, p<0.05), 22% had a decompensated perfusion
(vs. 15%; p<0.05) and 30% vs. 27% (n. s.) had mediasclerosis.
In the groups of subjects with compensated and
decompensated perfusion we performed in the popula-
tion of the structured health care program 45 infrapopliteal
bypass reconstructions (vs. 15 in the controls) and 81 vs.
39 iliacal or femoral arterial reconstructions.
445 vs. 152 patients underwent percutaneous translu-
minal angioplasty and another 116 patients were treated
by prostaglandins, low-dose urokinase, or “stem cells”.
75 controls were treated by prostaglandins.
Detailed data on diabetic complications of both groups
are given at Table 2.
Mortality
The mortality rate during the initial hospitalization in
the group treated by the structured health care program
was 2.5% (n = 17). In contrast the controls had a signifi-
cantly higher age adjusted mortality rate of 9.4% (n=48,
p<0.001). After two years, 419 patients of the structured
health care group (63.3% of the original cohort) could
still be examined. Altogether, 143 patients (20.9%) died,
and 54 (7.9%) dropped out for various reasons and 68Table 2 Diabetic complications of the subjects in the
structured health care program and controls
Parameter SHC Controls
n (%) (n%)
VPT < 4/8 654 (95.6) 457 (90.0)
CAN 289 (42.3) n. d.
retinopathy
background 561 (82.0) n. d.
proliferative 55 (8.0) n. d.
Microalbuminuria 269 (39.2) n. d.
creatinine >130μmol/l 104 (15.2) 71 (14.1)
prior amputation 249 (36.4)
toe 152 (22.2) n. d.
transmetatarsal 34 (5.0) n. d.
below the knee 40 (5.8) 73 (14.4)
above the knee 23 (3.4) 53 (10.5)
CAD 567 (82.9) 396 (78.1)
prior AMI 47 (6.9) 41 (8.0)
prior stroke 51 (7.5) 48 (9.5)
hypertension 621 (90.8) 441 (87.0)
dyslipidemia 540 (78.9) n. d.
smoking 231 (33.8) 158 (31.2)
VPT vibration perception threshold.
CAN cardiac anatomic neuropathy.
CAD coronary artery disease.
SHC structured health care group.(9.9%) were lost to follow-up. 96 patients in total died in
the first year and 47 in the second year of follow-up.
The subjects of the control group had no follow-up
examinations.
Course of lesions (Table–3)
The prevalence of wound severity by ulcer grade and
stage of both, the patients from the SHC and the control
group and the course of the lesions during the two-year
follow-up in the group of patients in the SHC program
are outlined in Table 3 at admission into the SHC
program, about 88% of all lesions were found to penetrate
to tendon, capsule, bone or joint or had a local necrosis
(modified UT-Wagner grade 2, 3 and 4) and were infected
and ischemic (UT- stage D).
At discharge about 30% of all foot wounds were healed.
The grade/stage OC signifies healing with continuing
compensated ischemia. Another 52% of foot wounds
were improved to modified UT-Wagner grade 1.
At the 2 year follow–up examination 74% of the ulcers
were healed completely and another 17% were in
UT-Wagner grade 1.
Therefore, during the two-year follow-up more than
90% of the ulcers in the patients from the structured
health care program were either healed completely or
significantly improved.
19.6% of the initial patient group suffered from an
ulcer relapse at any point of the study, representing
almost the entirety of wounds not healed.
At admission to the clinic about 79% of all lesions
in the control group were found to be in modified
UT-Wagner grade 2, 3 or 4 and in UT stage D.
At discharge from the clinic 23.0% of all foot wounds
of the controls were healed and 49.8% were in modified
UT-Wagner grade 1. These subjects had no follow-up
control.
The comparison of ulcer healing rates according to the
modified UT wound classification system is demon-
strated at Figure 2.
The diabetic foot subjects included into the structured
health care program had a comparable severity of the
lesions at admission to the hospital as compared to the
controls.
The average severity of diabetic foot wounds at
discharge from the clinic between the treatment groups
was tested after adjustment by age, ulcer severity (modified
UT classification at admission), PAD, history of CHD,
hypertension, smoking and MA. The structured health
care group had a significantly (p=0.001) lower level of
ulcer severity at discharge compared to controls (Figure 2).
Amputations
32 subjects with diabetic foot in the structured health care
group underwent major amputation (amputation above
Table 3 Prevalence of wound severity by ulcer grade and stage (modified University of Texas wound classification
system) at admission to the clinics (A), discharge from the clinics (B) of the patients with diabetic foot treated by the
structured health care program and subjects with diabetic foot treated by standard care (controls) and 2 year follow-
up investigation of the structured health care group alone (C) (SHC n= 684, controls n= 508)
A (admission of patients to the clinic, baseline data)
Modified UT grade (Wagner) 0 1 2 3 4
UT stage SHC C SHC C SHC C SHC C SHC C
A n 1 21
% 0,1 4.1
B n 19 27 22 34 15 42
% 2.8 5.3 3.2 6.7 2.2 8.3
C n 2 41 12 8 34 11 9 2
% 0.3 8.1 1.8 1.6 5.0 2.2 1.3 0.4
D n 50 9 199 67 255 109 66 137
% 7.3 1.6 29.1 13.2 37.3 21.5 9.6 26.9
sum n 2 41 82 65 255 112 279 153 66 137
(%) 0.3 8.1 12.0 12.6 37.3 22.1 40.8 30.2 9.6 26.9
B (discharge of patients from the clinic)
Modified UT grade (Wagner) 0 1 2 3 4
UT stage SHC C SHC C SHC C SHC C SHC C
A n 17 31 8
% 2.5 6.7 1.2
B n 10 4 4
% 1.5 0.9 0.9
C n 172 75 261 19 38 20 5 18
% 25.8 16.3 39.1 4.1 5.6 4.3 0.7 3.9
D n 65 206 56 25 30 32 5 26
% 9.7 44.8 8.4 5.4 4.5 6.9 0.7 5.7
sum n 189 106 344 229 94 49 35 50 5 26
(%) 28.3 23.0 51.5 49.8 13.9 10.6 5.2 10.5 0.7 5.7
C (2 year follow-up of the disease management program group)
Modified UT grade (Wagner) 0 1 2 3 4
UT stage SHC SHC SHC SHC SHC
A n 58
% 13.8
B n 1 1
% 0.2 0.2
C n 253 58 10 1
% 60.4 13.8 2.4 0.2
D n 13 19 2 3
% 3.1 4.5 0.5 0.7
sum 311 72 29 4 3
(%) 74.2 17.1 6.9 0.9 0.9
SHC structured health care program.
Controls.
UT modified University of Texas wound classification system.
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rate 4.7%). During the two year follow-up 22 subjects
underwent major amputation (major amputation rate
during follow-up 3.2%).
The major amputations were concentrated in the age
group > 65 years.
A relation between the number of major amputations
and the grade and stage of the foot lesion could not be
established due to the low number of major amputations.
215 out of 684 patients (31.4%) experienced minor
amputations (distal of the ankle); the rate of major/
minor amputations was about 1:7.
Controls underwent major amputation in 110 cases
(21.7%, p< 0.0001 (age adjusted) compared to structured
health care group). 179 control patients had minor
amputations (35.2%); accordingly, the ratio of major/
minor amputations was 1:1.6.
Discussion
Data depicting the outcome of different treatment regimes
for the diabetic foot are heterogeneous throughout
literature. Currently, prospective long-term studies
regarding diabetic foot management are almost scarce.
We therefore conducted this prospective observational
study with an 8 year inclusion and a two-year post-
treatment observation period. The central objective of the
project, a significant reduction of major amputation in
diabetic foot patients, has been achieved by introducing a
structured health care program for the diabetic foot. The
number of amputations above the ankle in this study was
4.7% at the end of the acute hospital treatment period
and, thus, very low, in comparison to the control group,
treated by usual care of diabetic foot.
This is comparable to the data published by Canavan
et al. [11] from the South Tees region in England,
demonstrating that an intensified care for patients with
diabetic foot results in a drastic reduction of lower
extremity amputation (LEA) rates. In this study, the
relative risk of a person with diabetes undergoing LEA
declined from 46 times of that of a person without
diabetes to 7.7 at the end of a 5 year follow up period
from 1995 to 2000 and comparable data were published
by Krishnan et al. [12].
In a prospective study of a cohort of 291 patients
hospitalized for diabetic foot infection at 38 French
centres, a LEA rate of 35% during hospital treatment
was documented. During the 1 year follow – up LEA
rate increased to 48% [13].
The results of centers specialized in the treatment of
patients with diabetic foot in Great Britain (Manchester)
and the US (San Antonio) were reported by Oyibo et al.
[14]. In 1998 and 1999, this observational study
comprised 194 patients. The wound data were classified
according to the original UT-System.Only 26% of the ulcers were described to be
neuroischemic. The great majority of findings (67%)
were neuropathic ulcers. According to these data, a high
healing rate should have been expected. However, 14%
of the patients underwent LEA due to non-healing
ulcers. Four percent of the patients died, and 16% had
persistent ulcers at the end of the study. Altogether, 65%
of the initially existing ulcers healed completely. The
likelihood of calf amputations was 15 times higher for
patients with diabetic foot affected by ischemia or infec-
tion compared to patients without these conditions.
These data are comparable well to our results
presented here especially because the UT system or the
modified UT system was used in these studies.
In the EURODIALE-Study, conducted at 14 hospitals
in 10 European countries, a major amputation rate of
5.1% in 1229 patients was documented [15].
Severe limb ischemia, as defined by an ABI of <0.5,
was present in 12% of these patients. In our study
decompensated perfusion was found in 22% of all
patients in the disease management program group.
Peripheral vascular disease (PAD) is significantly asso-
ciated with reduced survival in foot ulcer patients.
Faglia et al. [16] addressed the problem of occlusive
peripheral arterial disease in subjects with diabetic foot
ulcers. From 1993 to 1995, 121 patients with diabetic
foot were admitted consecutively to Milan University
hospital. Angiography was carried out in 104 subjects.
The most interesting data in this study was the extraor-
dinary high rate of occlusive arterial disease. Only one
out of 104 subjects did not have hemodynamically
significant stenoses. Nearly half of the patients had
stenoses in the popliteal and infrapopliteal axis only.
Because neuropathy was also found to be very common
too (90 subjects = 86.5%), the prevalent picture was the
neuroischemic foot. Similary, more than 80% of all
subjects in our study had neuroischemic diabetic foot. In
2009, the same group reported even more impressive data
on 554 patients with critical limb ischemia (CLI) [17].
In these patients, peripheral angioplasty (PTA) was
performed in 75% and bypass graft (BPG) in 21%.
Neither PTA nor BPG were possible in 5% of the subjects.
LEA rate in this highly complicated group of patients
was 13.4% (8% in PTA patients, 21% BPG and 59% in the
subgroup that received no revascularisation). Comparable
data were reported by Uccioli et al. [18]. It can be con-
cluded from these studies that the degree of PAD has a
drastic effect on the outcome of diabetic foot therefore
limiting the comparability of most of these studies
performed at different centers.
The long-term outcome in terms of amputations and
mortality in patients with new-onset diabetic foot ulcers
in subgroups stratified by etiology was examined by
Moulik et al. [19]. Five-year mortality was 18%, 45% and
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respectively.
The rates of mortality also vary significantly between
different studies, most likely due to differences in the
proportion and degree of CLI, history of foot ulcer or
amputation and impaired renal function.
The Milan group [20] evaluated new ulceration, new
major amputation and survival rates of 115 subjects with
diabetes hospitalized for foot ulceration from 1990 to
1993. One of the main results was the mortality rate of
44% during the follow-up period of 6.5 years. After two
years, the mortality rate was around 15% regarding
subjects without and more than 40% in subjects with
major amputation. The overall mortality rate was 20%
after two years. These data are comparable with the
mortality rates reported in our present study.
Holstein and Sorensen [21] reported a retrospective
study of 162 patients with diabetes with foot ulcers
admitted to a vascular surgical department with a new
multidisciplinary diabetic foot unit.
The survival rate after 24 months was 68% in subjects
with diabetic foot due to peripheral neuropathy without
the need for arterial reconstruction, 64% in patients with
limb-threatening ischemia undergoing revascularization,
and 16% in diabetic foot with limb-threatening ischemia
without possible option for revascularization.
Williams et al. [22] recently have shown that the
implementation of a multidisciplinary diabetic foot team
into a department of vascular surgery was associated with
improved outcomes for patients with diabetic foot. The
improvements were not related to increased numbers of
vascular procedures or hospitalizations, but coincide with
greater proportion of patients attending this foot unit.
There is considerable variability in the reported inci-
dence rates of amputation among different countries
and various points in time [23-27]. In general a signifi-
cant reduction in LEA in diabetic foot appears to be
realized [28,29]. As compared to the data reported in the
literature with major amputation rates of 8-40%, the rate
of 4.7% of major amputation in our patients treated by the
structured health care program documents a significant
improvement.
Armstrong et al. [2] reported that the frequency of
major amputation increases with advanced wound
progression as determined by the Wagner classification
of lesions or with an infection (stage B according to UT
system), or ischemia (stage C). A simultaneous occurrence
of infection and ischemia (stage D) would further increase
the likelihood for LEA.
Thus, if the wound extends to the bone and an infec-
tion and ischemia exist (Wagner grade 3 and higher) it
is very likely that LEA will be necessary. However, due
to the very small number of amputations, the data of
our study do not confirm this.The significantly higher age of the controls in our study
may potentially affect wound healing, mortality and
amputation rate. Therefore, the data were adjusted to age,
PAD, history of CHD, hypertension, smoking and MA.
Moreover, as compared to the controls, the state of
perfusion was significantly worse in the patients treated
in the structured health care program. Therefore, the
significantly higher rate of amputations (4.6-fold) in the
control group of our study may not be related to age.
Similarly, the increased mortality rate in the controls
(3.8-fold) may not be attributed to age differences since
both groups (controls/structured health care) did not
differ with respect to their general and disease-related
morbidity (Table 1).
Patients with diabetic complications and diabetic foot
problems in particular are among the most complex and
vulnerable of all patient populations and intensive effort
is required in these patients in order to accomplish limb
preservation [30,31]. The implementation of the struc-
tured health care program by the means of a multidis-
ciplinary diabetic foot team is essential to reduce LEA
successful [28,32].
The structured health care program for diabetic foot
introduced here includes structured outpatient, inpatient
and rehabilitative treatment. Since the major amputation
rate of the control group without the structured health
care program was about 5 times higher, we conclude that
a the introduction of a structured health care program can
significantly reduce the number of major amputations in
patients with diabetic foot.
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